The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

A third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way ...

Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently. This condition, known as demyelination, disrupts motor function, sensory ...

The North Chicago-based drugmaker is relying on newer treatments to make up for falling sales of Humira, its aging ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

A University of Pacific professor and his team developed a drug delivery system that they say could offer a game-changing ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...